Locations:
Search IconSearch

Tag: MOG antibody-associated disease (MOGAD)

two brain MRIs side by side

Brain Volume Changes and Disability in MOGAD: Defining Differences From Other Demyelinating Diseases

Despite less overall volume loss than in MS and NMOSD, volumetric changes correlate with functional decline

Dr. Amy Kunchok against decorative background
July 16, 2024/Neurosciences/Podcast

What to Know About Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) (Podcast)

It’s time to get familiar with this emerging demyelinating disorder

23-NEU-3839388-CQD-Hero-650×450

Postpartum Presentation of a Rare CNS Demyelinating Disorder

Diagnosis and treatment of MOG antibody-associated disease

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad